Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Salvati

Showing results (61-70 of 220) with videos related to

Pageof 22
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonistsAaron Balog, Mark E Salvati, Weifang Shan, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Identification of 2-amino-5-(thioaryl)thiazoles as inhibitors of nerve growth factor receptor TrkASoong-Hoon Kim, John S Tokarski, Kenneth J Leavitt, et al.
Cancer Research|August 6, 2009
Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancerRicardo M Attar, Maria Jure-Kunkel, Aaron Balog, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonistsMark E Salvati, Aaron Balog, Weifang Shan, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2014
Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitorsYufeng Wang, Wu Yang, Heather J Finlay, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate CancerAaron Balog, Richard Rampulla, Gregory S Martin, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2012
Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitorsMichael M Miller, Yalei Liu, Ji Jiang, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of a Lead Triphenylethanamine Cholesterol Ester Transfer Protein (CETP) InhibitorHeather J Finlay, Ji Jiang, Richard Rampulla, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2010
Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonistsHai-Yun Xiao, Aaron Balog, Ricardo M Attar, et al.
Pageof 22

Showing results (61-70 of 220) with videos related to

Sort By:
Pageof 22
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonistsAaron Balog, Mark E Salvati, Weifang Shan, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Identification of 2-amino-5-(thioaryl)thiazoles as inhibitors of nerve growth factor receptor TrkASoong-Hoon Kim, John S Tokarski, Kenneth J Leavitt, et al.
Cancer Research|August 6, 2009
Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancerRicardo M Attar, Maria Jure-Kunkel, Aaron Balog, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonistsMark E Salvati, Aaron Balog, Weifang Shan, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2014
Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitorsYufeng Wang, Wu Yang, Heather J Finlay, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate CancerAaron Balog, Richard Rampulla, Gregory S Martin, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2012
Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitorsMichael M Miller, Yalei Liu, Ji Jiang, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of a Lead Triphenylethanamine Cholesterol Ester Transfer Protein (CETP) InhibitorHeather J Finlay, Ji Jiang, Richard Rampulla, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2010
Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonistsHai-Yun Xiao, Aaron Balog, Ricardo M Attar, et al.
Pageof 22